Skip to main content
SpringerLink
Log in

HSV-1’s contribution as a vector for gene therapy

  • Correspondence
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sheridan, C. Nat. Biotechnol. 40, 809–811 (2022).

    Article  CAS  Google Scholar 

  2. Miyagawa, Y. et al. Proc. Natl Acad. Sci. USA 112, E1632–E1641 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Preston, C. M. J. Gen. Virol. 81, 1–19 (2000).

    CAS  PubMed  Google Scholar 

  4. Fink, D. J. et al. Ann. Neurol. 70, 207–212 (2011).

    Article  CAS  Google Scholar 

  5. Wang, Q., Guo, J. & Jia, W. Gene Ther. 4, 1300–1304 (1997).

    Article  CAS  Google Scholar 

  6. Aldrak, N. et al. Cells 10, 1541–1558 (2021).

    Article  CAS  Google Scholar 

  7. Miller, C. S. & Danaher, R. J. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 105, 43–50 (2008).

    Article  Google Scholar 

  8. Goss, J. R. et al. Diabetes 51, 2227–2232 (2002).

    Article  CAS  Google Scholar 

  9. Han, F. et al. J. Virol. 92, e00536-18 (2018).

    Article  Google Scholar 

  10. Gomez-Sebastian, S., Gimenez-Cassina, A., Diaz-Nido, J., Lim, F. & Wade-Martins, R. I. Mol. Ther. 15, 248–254 (2007).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. EG427 Pinpoint Gene Therapy, Paris, France

    Alberto L. Epstein

Authors
  1. Alberto L. Epstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alberto L. Epstein.

Ethics declarations

Competing interests

A.L.E. is a cofounder of, is CSO of, and has an equity interest in EG427.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Epstein, A.L. HSV-1’s contribution as a vector for gene therapy. Nat Biotechnol 40, 1316 (2022). https://doi.org/10.1038/s41587-022-01449-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-022-01449-1

  • Springer Nature America, Inc.

Search

Navigation